| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2025 | Dec, 2025 | Dec, 2025 |
| Sales | 25,530 | 29,120 | 0 | 0 | 0 |
| Sales Growth | -12.33% | unch | unch | unch | unch |
| Net Income | 1,550 | 4,330 | 0 | 0 | 0 |
| Net Income Growth | -64.20% | unch | unch | unch | unch |
Zhengye Biotechnology Holding Limited (ZYBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.
Fiscal Year End Date: 12/31